Artelo Biosciences (ARTL)
(Delayed Data from NSDQ)
$1.34 USD
0.00 (-0.13%)
Updated Apr 25, 2024 12:36 PM ET
After-Market: $1.31 -0.03 (-2.24%) 6:36 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.34 USD
0.00 (-0.13%)
Updated Apr 25, 2024 12:36 PM ET
After-Market: $1.31 -0.03 (-2.24%) 6:36 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Zacks News
Artelo's (ARTL) FABP5 Inhibitor Effective in Pre-Clinical Study
by Zacks Equity Research
Artelo Biosciences (ARTL) reports positive pre-clinical data from one of its FABP5 inhibitors in anxiety-related disorders. Stock up.
Is Artelo Biosciences, Inc. (ARTL) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Artelo Biosciences, Inc. (ARTL) and Avalo Therapeutics, Inc. (AVTX) have performed compared to their sector so far this year.